{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:42Z","timestamp":1786998462078,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ygyno.2015.04.029","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T02:33:00Z","timestamp":1430188380000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals"],"prefix":"10.1016","volume":"138","author":[{"given":"Terri","family":"Febbraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katina","family":"Robison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Scalia","family":"Wilbur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Laprise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Bregar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrishali","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Legare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Stuckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.04.029_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nature12981","article-title":"Realizing the promise of cancer predisposition genes","volume":"505","author":"Rahman","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ygyno.2015.04.029_bb0015","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in a case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0020","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/jnci\/90.23.1824","article-title":"Effects of BRCA 1 and BRCA 2 on the association between breast cancer risk and family history","volume":"90","author":"Claus","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"21","key":"10.1016\/j.ygyno.2015.04.029_bb0025","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Aslop","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2015.04.029_bb0030","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.04.029_bb0035","first-page":"700","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"68","author":"Zhang","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2010.05.011","article-title":"Prevalence of BRCA 1 and BRCA 2 germ line mutations among with carcinoma of the fallopian tube","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0045","first-page":"128","article-title":"Current and emerging trends in Lynch syndrome identification in women with endometrial cancer","volume":"114","author":"Resnick","year":"2009"},{"key":"10.1016\/j.ygyno.2015.04.029_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA mismatch repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.04.029_bb0055","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumors in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ygyno.2015.04.029_bb0070","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2004.04.086","article-title":"Impact of BRCA1\/BRCA2 counseling and testing on newly diagnosed breast cancer patients","volume":"22","author":"Schwartz","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0738-3991(03)00122-8","article-title":"Breast cancer risk counseling improves women's functioning","volume":"53","author":"Bowen","year":"2004","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0080","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0085","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduced breast cancer risk in BRCA1 and BRCA 2 mutation carriers: the PROSE Study Group","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0090","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/IGC.0b013e31821bc7e3","article-title":"Risk reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical pathological protocol","volume":"21","author":"Powell","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2015.04.029_bb0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/cge.12091","article-title":"Changes in screening behaviors and attitudes toward screening from pretest genetic counseling to post disclosure in Lynch syndrome families","volume":"83","author":"Burton-Chase","year":"2013","journal-title":"Clin. Genet."},{"issue":"3","key":"10.1016\/j.ygyno.2015.04.029_bb0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/IGC.0b013e318280f2b4","article-title":"Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?","volume":"23","author":"Powell","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.04.029_bb0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predisposition","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.04.029_bb0115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","article-title":"ACOG committee of Genetics ACOG Practice Bulletin No 103: hereditary breast and ovarian cancer syndrome","volume":"113","author":"American College of Obstetrics and Gynecologist","year":"2009","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2015.04.029_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00125817-200103000-00006","article-title":"Oncologists' opinions on genetic testing for breast and ovarian cancer","volume":"3","author":"Culver","year":"2001","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2015.04.029_bb0125","first-page":"662","article-title":"Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic","volume":"22","author":"Petzel","year":"2013"},{"key":"10.1016\/j.ygyno.2015.04.029_bb0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2015.04.029_bb0135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2013.51.4661","article-title":"Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology quality oncology practice initiative","volume":"32","author":"Wood","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0140","author":"American Cancer Society"},{"issue":"81","key":"10.1016\/j.ygyno.2015.04.029_bb0150","first-page":"1","article-title":"Healthcare providers and direct-to-consumer access and advertising of genetic testing in the United States","volume":"3","author":"Meyers","year":"2011","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.ygyno.2015.04.029_bb0155","first-page":"1730","article-title":"Genetic testing for cancer susceptibility","volume":"14","author":"Statement of the American Society of Clinical Oncology","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.04.029_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1524-4741.2003.09105.x","article-title":"Prevalence of family history of breast and ovarian cancer in a single primary care practice using self-administered questionnaire","volume":"9","author":"Hughes","year":"2003","journal-title":"Breast J."},{"issue":"9","key":"10.1016\/j.ygyno.2015.04.029_bb0165","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/cncr.21393","article-title":"Prevalence of hereditary breast\/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population","volume":"104","author":"Dominguez","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.04.029_bb0170","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1542-3565(04)00352-0","article-title":"Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients","volume":"2","author":"Grover","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2013.05.003","article-title":"Keeping it simple: genetics referrals for all invasive serous ovarian cancers","volume":"130","author":"Demsky","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0180","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2354.2009.01067.x","article-title":"Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women","volume":"19","author":"Bruno","year":"2010","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.ygyno.2015.04.029_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2007.11.6905","article-title":"Effect of BRCA1, 2 mutations on long term survival of patients with invasive ovarian cancer: the National Israeli study of ovarian cancer","volume":"26","author":"Chetrit","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.04.029_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2008.06.016","article-title":"What women with ovarian cancer think and know about genetic testing","volume":"111","author":"Lacour","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.04.029_bb0195","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/1055-9965.EPI-03-0545","article-title":"Utilization of BRCA1\/BRCA2 mutation testing in newly diagnosed breast cancer patients","volume":"14","author":"Schwartz","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2015.04.029_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk","volume":"13","author":"Levy","year":"2011","journal-title":"Genet. Med."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815008586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815008586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T22:50:39Z","timestamp":1537656639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815008586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0090825815008586"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.04.029","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}